Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of EZETROL vs Ezetimibe GPO 10 mg in Healthy Thai Volunteers (Fasting)
TCTR20171206001Not yet recruiting
- Sponsor
- Government Pharmaceutical Organization
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ezetimibe in hypercholesterolemia (2 arms), sponsored by Government Pharmaceutical Organization. Primary endpoint: Bioequivalence for ezetimibe. Planned start Jan 2018; status: not yet recruiting.
02
Drugs
ezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on TCTR20171206001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20171206001.